European Commission

News

Pharma incensed by EU's compulsory licensing proposal

Pharma industry bodies have slammed a proposal by the European Commission to set up a compulsory licensing (CL) framework for medicines in emergency situations, claiming t

News

EU sets up €100m fund to tackle health threats

The EU has set aside a €100 million block of financing for small- and medium-sized enterprises working on projects that could tackle public health threats, including emerg

News

Single market at heart of EU plans for pharma reform

The European Commission’s long-promised revamp of pharmaceutical legislation is finally unveiled, and it’s ambitious to say the least.

News

Rare Disease Moonshot launched at European Health Summit

A new initiative to boost research and development into rare and paediatric diseases launched last week, on Thursday 8th December, at the European Health Summit.

News

EC approves Regeneron's Libtayo for advanced cervical cancer

Regeneron has announced that the European Commission (EC) has approved Libtayo (cemiplimab) as a monotherapy for the treatment of adult patients with second-line recurrent or metastatic cer

Views & Analysis

Economist Impact: World Cancer Series – pharmaphorum in atte...

It goes without saying that The Economist’s 8th Annual World Cancer Series congress was well-attended in Brussels this week, the unofficial capital of the European Union.

Pharma incensed by EU's compulsory licensing proposal

EU sets up €100m fund to tackle health threats

Single market at heart of EU plans for pharma reform

Rare Disease Moonshot launched at European Health Summit

EC approves Regeneron's Libtayo for advanced cervical cancer

Economist Impact: World Cancer Series – pharmaphorum in atte...

Novo Nordisk gets FDA okay for Wegovy pill

How to meet your physicians where they are online

European Commission

Editor's Picks